S

SHAM

400 employees

Sham Innovation Sante is an innovation capital vehicle controlled

Investor insights

Sectors invested in

Biotechnology8
Health Care8
Pharmaceutical6
Medical6
Metabolic Disease5
Hypoparathyroidism5
Wellness5
Endocrinology5
Therapeutic Peptides5
Rare Disease5
Endocrine Disease5
Medical Device3
Drug development1
Artificial Intelligence1
Machine Learning1
Health Diagnostics1
AI and radiology1
Software1
Manufacturing1
Life Science1

Funding rounds participated in

$10M sweet spot round size

Most of their 13 investments are in rounds between $4.1M and $19M

Basic info

Industry

insurance

Sectors

Insurance
Gestion des risques

Date founded

1927

Investments made

T

Therapixel raised $16M on May 12, 2022

Investors: Région Sud Investissement, IT-Translation, Omnes, FraserFinance, Relyens, Crédit Mutuel Innovation, Elaia, M CAPITAL and SHAM

G

Germitec S.A. raised $12M on May 10, 2022

Investors: GALIA GESTION, AQUITI Gestion, Financière ARBEVEL and SHAM

C

CAIRDAC raised $19M on March 31, 2022

Investors: Merieux Equity Partners, Supernova Invest GmbH, Carvest and SHAM

A

Amolyt Pharma raised $80M on September 16, 2021

Investors: OrbiMed Advisors, Sectoral Asset Management, Eurazeo, EQT Life Sciences, Pontifax Venture Capital and SHAM

U

Undisclosed raised $1.8M on August 2, 2021

Investors: Extens e-santé and SHAM

M

Mablink Bioscience raised $4.8M on April 27, 2021

Investors: Pertinence Invest SAS, Fournier-Majoie Foundation, Elaia and SHAM

A

Amolyt Pharma raised $75M on July 31, 2019

Investors: Partners HealthCare, Pontifax Venture Capital, EQT Life Sciences, OrbiMed Advisors and SHAM

C

Carthera raised $10M on December 12, 2018

Investors: PANAKES, Supernova Invest GmbH and SHAM

A

ANTABIO SAS raised $6.1M on July 12, 2018

Investors: BNP Paribas Développement and SHAM

U

Undisclosed raised $23M on January 17, 2018

Investors: BNP Paribas Développement, SOFIPACA Capital Investissement, Quest for Growth (QGPLF) and SHAM

FAQ